120
Participants
Start Date
August 31, 2001
Primary Completion Date
February 28, 2003
Study Completion Date
February 28, 2003
anti-IL-4 monoclonal antibody (pascolizumab)
Valley Clinical Research Center, Easton
University of Wisconsin Medical School, Madison
Clinical Research Institute, Minneapolis
ICSL Clinical Studies, Normal
The Clinical Research Center, LLC, St Louis
Center for Allergy, Asthma and Immunology, Creighton University, Omaha
Clinical Trials North Houston, Houston
National Jewish Medical and Research Center, Denver
Allergy Research Foundation, Los Angeles
Allergy Associates Medical Group, Inc., San Diego
Southern California Research, Mission Viejo
Clinical Trials of Orange Cnty., Inc., Orange
Allergy and Asthma Associates Santa Clara Valley Research Center, San Jose
Bensch Research Associates, Stockton
Allergy, Asthma, and Dermatology Research Center, LLC, Lake Oswego
Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital, Boston
New England Clinical Studies, North Dartmouth
Princeton Center for Clinical Research, Princeton
Lead Sponsor
Facet Biotech
INDUSTRY